14 completed. 14 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 14 |
| Phase 2 | 2 | Completed 2 |
Follow Peripheral Neuropathy: new trials by email Literature Review of Peripheral Neuropathy trials Research Report on Peripheral Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients" Pentoxifylline, Paclitaxel, Placebo - Breast Cancer Female, Peripheral Neuropathy | Phase 2 / Phase 3 | Completed | Ain Shams University | 66 | 2021-10-03 | 2024-01-23 |
| Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy Salsalate, PLACEBO - Type 1 Diabetes, Peripheral Neuropathy | Phase 2 / Phase 3 | Completed | University of Michigan | 61 | 2016-10-01 | 2025-05-16 |
| Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain Lidocaine, Placebo - Peripheral Neuropathy | Phase 3 | Completed | Mahidol University | 29 | 2014-08-01 | 2022-11-30 |
| Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer duloxetine hydrochloride, placebo - Neurotoxicity, Pain | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 231 | 2008-04-01 | 2017-04-26 |
| Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients ketamine/amitriptyline NP-H cream, placebo - Neurotoxicity, Pain | Phase 3 | Completed | Gary Morrow | 462 | 2007-10-01 | 2015-11-09 |
| Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer glutamic acid, placebo - Kidney Cancer, Leukemia | Phase 3 | Completed | University of South Florida | 250 | 2007-05-01 | 2021-08-11 |
| A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain Sativex®, Placebo - Pain, Peripheral Neuropathy | Phase 3 | Completed | Jazz Pharmaceuticals | 19 | 2007-03-01 | 2023-05-03 |
| Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy pregabalin - Peripheral Neuropathy, HIV Infections | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 220 | 2006-02-01 | 2021-01-22 |
| Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy pregabalin, Placebo - HIV Infections, Peripheral Neuropathy | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 302 | 2005-10-01 | 2021-02-09 |
| A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain. Sativex® - Pain, Peripheral Neuropathy | Phase 3 | Completed | Jazz Pharmaceuticals | 380 | 2005-10-01 | 2023-05-03 |
| A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia Sativex, Placebo - Pain, Peripheral Neuropathy | Phase 3 | Completed | Jazz Pharmaceuticals | 246 | 2005-08-01 | 2023-05-03 |
| Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy glutamine, Placebo - Peripheral Neuropathy, Breast Cancer | Phase 3 | Completed | Weill Medical College of Cornell University | 30 | 2003-12-01 | 2018-06-06 |
| Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer amifostine trihydrate - Gestational Trophoblastic Tumor, Neurotoxicity | Phase 3 | Completed | Gynecologic Oncology Group | 100 | 2003-03-01 | 2013-07-09 |
| A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia. Sativex®, Placebo - Pain, Peripheral Neuropathy | Phase 3 | Completed | Jazz Pharmaceuticals | 125 | 2002-05-01 | 2023-04-12 |
Peripheral Nervous System Diseases (14) · Pain (7) · Neurotoxicity Syndromes (4) · Breast Neoplasms (2) · HIV Infections (2) · Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Gestational Trophoblastic Disease (1) · Hydatidiform Mole (1) · Hyperalgesia (1) · Inflammation (1) · Kidney Neoplasms (1) · Leukemia (1)
Nervous System Diseases (14) · Neuromuscular Diseases (14) · Neurologic Manifestations (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Chemically-Induced Disorders (4) · Immune System Diseases (4) · Neoplasms (4) · Poisoning (4) · Urogenital Diseases (4) · Infections (3) · Neoplasms by Site (3) · Virus Diseases (3) · Blood-Borne Infections (2) · Breast Diseases (2)
nabiximols (4) · Pregabalin (2) · Amifostine (1) · Duloxetine Hydrochloride (1) · Glutamic Acid (1) · Glutamine (1) · Ketamine (1) · Lidocaine (1) · Paclitaxel (1) · Pentoxifylline (1) · Sugars (1) · glutamic acid diethyl ester (1) · salicylsalicylic acid (1)
Jazz Pharmaceuticals (4) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2) · Ain Shams University (1) · Alliance for Clinical Trials in Oncology (1) · Gary Morrow (1) · Gynecologic Oncology Group (1) · Mahidol University (1) · University of Michigan (1) · University of South Florida (1) · Weill Medical College of Cornell University (1)
United States (8) · United Kingdom (4) · Puerto Rico (2) · Egypt (1) · Thailand (1)
Barbara Hoggart, MBBS, FRCA (2) · David R. Freyer, DO, MS (1) · Ellen L. Smith, PhD, ARNP, AOCN (1) · Eric Sandler, MD (1) · Linda Vahdat, MD (1) · Mick Serpell, MB ChB, FRCA (1) · Rodica Pop-Busui, MD, PhD (1) · Scott Bradfield, MD (1) · Steven C. Plaxe, MD (1) · Supriya Mohile, MD (1) · Suratsawadee Wangnamthip, M.D. (1) · Turo Nurmikko, MB BS PhD (1)
PMID 14745057, PMID 16235318, PMID 17997224, PMID 23549581, PMID 24420962, PMID 24531792, PMID 26603828, PMID 39727210, PMID 8857633, PMID 9415498
U10CA037420 (1), U10CA081920 (1)